What is QSAR?, introduction to 3D QSAR, CoMFA, CoMSIA, Case Study on CoMFA contour maps analysis and CoMSIA interactive forces between ligand and receptor, various Statistical techniques involved in QSAR
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTShikha Popali
THE PHARMACOPHORE MAPPING AND VIRTUAL SCRRENING , THESE PRESENTATION INCLUDES THE DEATIL ACCOUNT ON PHARMACOPHORE, MAPPING, ITS IDENTIFIATION FEATURES, ITS CONFORMATIONAL SEARCH, INSILICO DRUG DESIGN, VIRTUAL SCREENING, PHARMACOPHORE BASED SCREENING
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)AkshayYadav176
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
Concept of pharmacophore, Pharmacophore mapping, Identification of pharmacophore features and pharmacophore modeling, Conformation search used in pharmacophore mapping, Virtual screening.
What is QSAR?, introduction to 3D QSAR, CoMFA, CoMSIA, Case Study on CoMFA contour maps analysis and CoMSIA interactive forces between ligand and receptor, various Statistical techniques involved in QSAR
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTShikha Popali
THE PHARMACOPHORE MAPPING AND VIRTUAL SCRRENING , THESE PRESENTATION INCLUDES THE DEATIL ACCOUNT ON PHARMACOPHORE, MAPPING, ITS IDENTIFIATION FEATURES, ITS CONFORMATIONAL SEARCH, INSILICO DRUG DESIGN, VIRTUAL SCREENING, PHARMACOPHORE BASED SCREENING
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)AkshayYadav176
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
Concept of pharmacophore, Pharmacophore mapping, Identification of pharmacophore features and pharmacophore modeling, Conformation search used in pharmacophore mapping, Virtual screening.
Hey students here i am attaching the powerpoint presenatation on the Receptor/enzyme-interaction and its analysis, Receptor/enzyme cavity size prediction, predicting
the functional components of cavities and the concept regarding the fragment based drug design.
Quantum Mechanics in Molecular modelingAkshay Kank
This slides gives you the information related to computer aided drug design and its application in drug discovery. Also you learn the Quantum mechanics related to the molecular mechanics. Theory related to molecular modeling and how the molecular modeling helps in drug discovery.
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptxMO.SHAHANAWAZ
Detail about PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW MOLECULES AND IT’S IMPORTANCE IN DRUG DISCOVERY, including DESCRIPTORS OF ADMET PREDICTION, DATASETS USED IN ADMET PREDICTION
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptxMO.SHAHANAWAZ
Point to point M.pharm CADD presentation on MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING, Dihydro Folate reductase Inhibiter (Methotrexate)
Hey students here i am attaching the powerpoint presenatation on the Receptor/enzyme-interaction and its analysis, Receptor/enzyme cavity size prediction, predicting
the functional components of cavities and the concept regarding the fragment based drug design.
Quantum Mechanics in Molecular modelingAkshay Kank
This slides gives you the information related to computer aided drug design and its application in drug discovery. Also you learn the Quantum mechanics related to the molecular mechanics. Theory related to molecular modeling and how the molecular modeling helps in drug discovery.
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptxMO.SHAHANAWAZ
Detail about PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW MOLECULES AND IT’S IMPORTANCE IN DRUG DISCOVERY, including DESCRIPTORS OF ADMET PREDICTION, DATASETS USED IN ADMET PREDICTION
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptxMO.SHAHANAWAZ
Point to point M.pharm CADD presentation on MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING, Dihydro Folate reductase Inhibiter (Methotrexate)
molecular docking its types and de novo drug design and application and softw...GAUTAM KHUNE
This ppt deals with all the aspects related to molecular docking ,its types(rigid ,flexible and manual) and screening based on it and also deals with de novo drug design , various softwares available for docking methodologies and applications for molecular docking in new drug design
Computer aided drug design Fragment Based Drug Design/ Medicinal Chemistry, I...SourajyotiGoswami
Fragment-based drug design (FBDD) is a powerful technique in medicinal chemistry that utilizes computer simulations to discover new drug candidates. It works like building a Lego model:
The Foundation: Fragment Library: A collection of small, chemically diverse molecules serves as the building blocks.
Finding the Perfect Fit: Using computational tools like docking simulations, scientists virtually screen these fragments against a 3D structure of the disease target (e.g., a protein). The goal is to identify fragments that bind well to specific pockets on the target.
Connecting the Dots: Once promising fragments are identified, computational tools help scientists link them together to create a more potent drug molecule.
In-silico Refinement: Throughout the process, computer simulations predict properties like drug-likeness and potential side effects, allowing for early optimization of the drug candidate.
FBDD offers several advantages. It can be effective even when little is known about the target, and it prioritizes smaller, more manageable fragments, often leading to more drug-like final compounds.
This in-silico approach streamlines the drug discovery process, saving time and resources compared to traditional methods. It's a testament to the power of computers in aiding the design of life-saving medications.
PRESENTED BY: HARSHPAL SINGH WAHI, SHIKHA D. POPALI
USEFUL FOR PHARMACY STUDENTS AND ACADEMICS, INDUSTRIALS FOR MOLECULE DEVELOPMENT, MODELING, DRUG DISCOVERY, COMPUTATIONAL TOOLS, MOLECULAR DOCKING ITS TYPES, FACTORS AFFECTING, DIFFERENT STAGES, QSAR ADVANTAGES, NEED
MUTUAL PRODRUG IS DISCUSSED HERE IN DETAIL WITH ITS MULTIPLE TYPES AND FUCTIONAL GROUPS IT IS USE FOR AND FAILURE WITH PRODRUGS, WITH PHARMACEUTICAL EXAMPLES AND STRUCTURE ARE ALSO SHARE, SYNTHETIC APLLICATIONS.
HERE PRESENTS AN OLIGONUCLEOTIDE THERAPY, ITS INTRODUCTION TO OLIGONUCLEOTIDE, ITS TECHNIQUES, DEVELOPED METHODS AND THEIR APP,LICATIONS IN PHARMACEUTICAL ARE HERE DISCUSSED IN DETAIL
OXIDATION [PHARMACEUTICAL PROCESS CHEMISTRY]Shikha Popali
INTRODUCTION TO OXIDATION , WHICH IS PROCESS OF ADDITION OF OXYGEN TO THE COMPOUND IN RPOCESS CHEMISTRY AND LIQUID PHASE OXIDATION AND OTHER OXIDISING AGENTS ARE DISCUSSED.
Synthetic reagent and applications OF ALUMINIUM ISOPROPOXIDEShikha Popali
SYNTHETIC REAGENTS AND APPLICATIONS OF ALUMINIUM ISOPROPOXIDE ITS ALTERNATIVE NAMES AND ITS PHYSICAL PROPERTIRS , HANDLING, STORAGE, PRECAUTIONS, PREPARATIONS, SYNTHETIC APPLICATIONS
PTC IS THE PHASE TRANSFER CATALYSIS HERE TYPES OF PTC ARE DISCUSSED , THEORIES OF CATALYSIS AND MECHANISM OF PTC, ADVANTAGES OF PTC, APPLICATION OF PTC
SWERTIA CHIRATA NATURAL PRODUCT OF PHARMACEUTICALSShikha Popali
HERE THE NATURAL PRODUCT SERTIA CHIRATA IS DISCUSSED WITH ITS COMMON NAME, CHEMICAL CONSTITUENTS, ACTIVE CONSTITUENTS, SAR, MEDICINAL ACTIVITY AND MORE
THE DCC I.E. DICYCLOCARBODIIMDE IS A REAGENT AND HERE THE DETAIL ACCOUNT ON IT IS GIVEN INCLUDING MOLECULAR WEIGHT, STRUCTURE, SYNTHESIS AND PHYSICAL PARAMETERS AND APPLICATIONS FOR OTERS SYNTHESIS ARE ALSO DISCUSSED, THE DIFFERENT SYNTHESIS WITH DCC COMBINATION ARE ALSO MENTIONED
COMPARATIVE EVALUATION OF DIFFERENT PARACETAMOL BRANDSShikha Popali
THE PARACETAMOL TABLETS IS COMMONLY TAKEN AND PRESCRIBED FOR FEVER , SO HERE WE HAVE MADE PRACTICAL IS IT TRUE EVALUATION LABEL AND WHICH BRAND IS MORE SAFE.
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
How libraries can support authors with open access requirements for UKRI fund...
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
1.
2.
3. A drug can be discovered by following approach
1. modification of known molecule.
2. Synergestic or additive drugs in combination.
3. Screening of wide variety of drugs obtained from
natural sources, banks of previously discovered chemical
entities.
4. Identification or elucidation of entirely new target for
druG.
5.Rational drug design.
6.Genetic approaches.
4. Lead generation:
Natural ligand / Screening
Biological Testing
Synthesis of New Compounds
Drug Design Cycle
If promising
Pre-Clinical Studies
5. • A lead compound is a small molecule that serves as the starting
point for an optimization involving many small molecules that are
closely related in structure to the lead compound .
•
•
•
Many organizations maintain databases of chemical compounds.
Some of these are publically accessible others are proprietary
Databases contain an extremely large number of compounds (ACS
data bases contains 10 million compounds)
• 3D databases have information about chemical and geometrical
features
» Hydrogen bond donors
» Hydrogen bond acceptors
» Positive Charge Centers
» Aromatic ring centers
» Hydrophobic centers
6. There are two approaches to this problem
• A computer program AutoDock (or similar
version Affinity (accelrys)) can be used to search a
database by generating “fit” between molecule and
the receptor
• Alternatively one can search 3D pharmacophore
7. •
•
Drug design and development
Structure based drug design exploits the 3D structure
of the target or a pharmacophore
– Find a molecule which would be expected to interact
with the receptor. (Searching a data base)
– Design entirely a new molecule from “SCRATCH” (de
novo drug/ligand design)
• In this context bioinformatics and chemoinformatics
play a crucial role
8. Structure-based Drug Design (SBDD)
Molecular Biology & Protein Chemistry
3D Structure Determination of Target
and Target-Ligand Complex
Modelling
Structure Analysis
and Compound Design
Biological Testing
Synthesis of New Compounds
If promising
Pre-Clinical
Studies
Drug Design Cycle
Natural ligand / Screening
9. • So the two important features in drug design are
Target-receptor
lead- ligand
so there are different approaches based on structural availibility
receptor ligand approach comments
known known DOCK receptor
based
Programmes-AUTO-
DOCK
known unknown De novo based GROW, LEGEND
unknown known Ligand based QSAR
unknown unknown Combinational
based
10. De novo means start afresh, from the beginning, from
the scratch
It is a process in which the 3D structure of receptor is
used to design newer molecules
It involves structural determination of the lead target
complexes and lead modifications using molecular
modeling tools.
Information available about target receptor but no
existing leads that can interact.
11. PRINCIPLES OF DENOVO DRUG DESIGN
• Assembling possible compounds and evaluating their
quality.
• Searching the sample space for novel structures with
drug like properties.
Build model of
binding site
Protien structure
12. COMPUTER BASED DRUG DESIGN CONSISTS
OF FOLLOWING STEPS :-
1) Generation of potentiol primary constraints
2) Derivation of interaction sites
3) Building up methods
4) Assay (or ) scoring
5) Search strategies
6) Secondary target constraints
13. These are the molecules which set up a framework
for the desired structure with the required ligand receptor
interactions
- These are of 2 types:
1) receptor based:-
interactions of the receptor form basis for the
drug design.
2) ligand based:- ligand to the target functions as
a key.
Primary target constraints
14. • In denovo design, the structure of the target should
be known to a high resolution, and the binding to site
must be well defined.
• This should defines not only a shape constraint but
hypothetical interaction sites, typically consisting of
hydrogen bonds, electrostatic and other non-covalent
interactions.
• These can greatly reducing the sample space, as
hydrogen bonds and other anisotropic interactions can
define specific orientations.
15. Derivation of Interaction Sites:
• A key step to model the binding site as accurately as possible.
•
•
This starts with an atomic resolution structure of the active site.
Programs like UCSF , DOCK define the volume available to a
ligand by filling the active site with spheres.
• Further constraints follow, using positions of H-bond acceptors
and donors.
• Other docking algorithms, such as FLOG, GOLD, and
use an all-atom representations to achieve fine detail.
FlexiDock 16
• Ray-tracing algorithms, such as SMART,represent another strategy.
18. • A single key building block is the starting point or seed.
• Fragments are added to provide suitable interactions to
both key sites and space between key sites
• These include simple hydrocarbon chains, amines, alcohols,
and even single rings.
• In the case of multiple seeds, growth is usually simultaneous
and continues until all pieces have been integrated into a single
molecule.
21. The fragments, atoms, or building blocks are either placed at key
interaction sites
(or)
pre-docked using another program
They are joined together using pre-defined rules to yield a
complete molecule.
Linking groups or linkers may be predefined or generated to
satisfy all required conditions .
22. Lattice based method
• The lattice is placed in the binding site, and atoms
around key interaction sites are joined using the shortest
path.
• Then various iterations, each of which includes
translation, rotation or mutation of atoms, are guided by a
potential energy function, eventually leading to a target
molecule.
23.
24. Molecular Dynamics Methods:
• The building blocks are initially randomly placed and then by
MD simulations allowed to rearrange.
• After each rearrangement certain bonds were broken and the
process repeated.
• During this procedure high scoring structures were stored for
later evaluation.
25. SCORING
• Each solution should be tested to decide which is the most
promising.this is called as scoring.
• Programs such as LEGEND18, LUDI19, Leap-Frog16, SPROUT20,
HOOK21, and PRO-LIGAND22 attempt this using different scoring
techniques
• These scoring functions vary from simple steric
constraints and H-bond placement to explicit force fields and
empirical or knowledge-based scoring methods.
26. • Programs like GRID and LigBuilder3 set up a grid in the
binding site and then assess interaction energies by placing
probe atoms or fragments at each grid point.
• Scoring functions guide the growth and optimization of
structures by assigning fitness values to the sampled space
• Scoring functions attempt to approximate the binding free
energy by substituting the exact physical model with simplified
statistical methods.
• Force fields usually involve more computation than the
other types of scoring functions eg:- LEGEND
27. • Empirical scoring functions are a weighted sum of individual
ligand–receptor interactions.
• Apart from scoring functions, attempts have been made to
use NMR, X-ray analysis and MS to validate the fragments.
• Essential to know which path to follow
Types:-
1) Combinatorial search algorithms
• reducing the effective size of the solution space
• explore the space efficiently.
28. 2) Breadth first
• keep all possible solutions per step, and solves them all to end
structures.
• can only be done in a limited fashion, as an exhaustive search
would not be feasible.
3)Depth first
•
•
select the highest scoring solution per stepand proceeds.
This
solutions.
strategy may spontaneously generate nonsense
• Usually combinations of these last two are used;
for example, a breadth-first search could be done until the
solution space is relatively limited and in subsequent steps depth-
first searcheswould be used.
29. 4) Monte Carlo algorithms
• based on random sampling, and are usually tied with the
“Metropolis criterion”.
• After each
accepted if it is
modification, the partial solution is either
a better solution or rejected, based on the
difference of scoring of the modified versus the unmodified
structure.
5)Evolutionary Algorithms
• model natural processes, such as selection, recombination,
mutation, and migration, and work in a parallel manner.
• The number of partial solutions is not fixed and “evolves”
based on the “fitness” of the solutions.
30. • Binding affinity alone does not suffice to make an effective drug
molecule.
• Essential properties include effective Absorption, Distribution,
Metabolism, Excretion and Toxicity (ADMET).
•In general, an orally active drug has
• (a) not more than 5 hydrogen bond donors (OH and NH groups),
• (b) not more than 10 hydrogen bond acceptors (notably Nand O),
• (c) a molecular weight under 500 Da
• (d), a LogP (log ratio of the concentrationsof the solute in the
solvent) under 5.
•Using these rules as a filter, the resulting compounds are more
likely to have biological activity.
31. METHOD PROGRAMS AVAILABLE
Site point connection
method
LUDI
Fragment connection
method
SPLICE, NEW LEAD,
PRO-LIGAND
Sequential build up
methods
LEGEND, GROW, SPORUT
Random connection and
disconnection methods
CONCEPTS, CONCERTS,
MCDNLG
32. Applications:-
• Design of HIV I protease inhibitors
• Design of bradykinin receptor antagonist
• Catechol ortho methyl transferase inhibitor
Ex:- entacapone and nitecapone
• Estrogen receptor antagonist
• Purine nucleoside phosphorylase inhibitors
33. HIV 1 protease inhibitor
• HIV 1 protease is an enzyme crucial for
replication of HIV virus
• Inhibitors include saquinavir, ritonavir,
indinavar
• These drugs have been developed using this
appraoch
34. HIV 1 protease inhibitor
Structure of enzyme
Enzyme with inhibitor
35. limitations
• Rather slow and inefficient
• Ignores synthetic feasibility while constructing
structures
• Cannot be a sole basis for drug design
36. • Although a relatively new design method, de novo
design will play an ever-increasing role in modern drug
design.
• Though yet not able to automatically generate viable
drugs by itself, it is able to give rise to novel and often
unexpected drugs
• when coupled with HTS, is proving to reduce drug
design turn around
time.